{
    "info": {
        "nct_id": "NCT03232164",
        "official_title": "PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer",
        "inclusion_criteria": "* Prostate cancer pathologically proven by prostate biopsy (newly diagnosed for Sub-Study 1 and 4)\n* Prostate biopsy histology grade ≥ Gleason 1, 6, 3+4, or 4+3; positive biopsy >2 cores\n* Any PSA permitted\n* Two consecutive rising PSA values (Sub-Study 3 only)\n* Castrate-levels of testosterone - total testosterone < 50 ng/dL (Sub-Study 3 only)\n* Patients considered as candidates for and medically fit to undergo prostatectomy\n* At least 7 days after most recent prostate biopsy\n* Imaging evidence of suspected metastatic disease, including CT, bone scan, MRI, ultrasound or other PET modalities (Sub-Study 3 only)\n* New diagnosis of prostate cancer undergoing additional biopsy evaluation (Sub--Study 4 only)\n* Karnofsky performance status of at least 70 (Sub-Study 4 only)\n* General health and anatomy suitable to undergo transrectal ultrasound-MRI fusion biopsy of the identified lesions and standard 12 core sextent biopsy (Sub-Study 4 only)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Prior pelvic external beam radiation therapy or brachytherapy\n* Chemotherapy for prostate cancer\n* Androgen deprivation therapy for prostate cancer\n* Investigational therapy for prostate cancer (Sub-Study 3 Only)\n* Unable to lie flat during or tolerate PET/CT\n* Prior history of any other malignancy within the last 2 years, other than skin basal cell or cutaneous superficial squamous cell carcinoma that has not metastasized and superficial bladder cancer.\n* No prostatectomy scheduled more than 12 hours post imaging (Sub-Study 1 only)\n* Serum creatinine > 2 time the upper limit of normal\n* Total bilirubin > 3 times the upper limit of normal\n* Liver Transaminases > 5 times the upper limit of normal",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Castrate-levels of testosterone - total testosterone < 50 ng/dL (Sub-Study 3 only)",
            "criterions": [
                {
                    "exact_snippets": "Castrate-levels of testosterone - total testosterone < 50 ng/dL (Sub-Study 3 only)",
                    "criterion": "total testosterone",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50,
                                "unit": "ng/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any PSA permitted",
            "criterions": [
                {
                    "exact_snippets": "Any PSA permitted",
                    "criterion": "PSA level",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "any"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prostate biopsy histology grade ≥ Gleason 1, 6, 3+4, or 4+3; positive biopsy >2 cores",
            "criterions": [
                {
                    "exact_snippets": "Prostate biopsy histology grade ≥ Gleason 1, 6, 3+4, or 4+3",
                    "criterion": "prostate biopsy histology grade",
                    "requirements": [
                        {
                            "requirement_type": "grade",
                            "expected_value": [
                                "Gleason 1",
                                "Gleason 6",
                                "Gleason 3+4",
                                "Gleason 4+3"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "positive biopsy >2 cores",
                    "criterion": "positive biopsy cores",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "cores"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients considered as candidates for and medically fit to undergo prostatectomy",
            "criterions": [
                {
                    "exact_snippets": "Patients considered as candidates for ... prostatectomy",
                    "criterion": "candidate for prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "medically fit to undergo prostatectomy",
                    "criterion": "medical fitness for prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "medical fitness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* General health and anatomy suitable to undergo transrectal ultrasound-MRI fusion biopsy of the identified lesions and standard 12 core sextent biopsy (Sub-Study 4 only)",
            "criterions": [
                {
                    "exact_snippets": "General health and anatomy suitable to undergo transrectal ultrasound-MRI fusion biopsy of the identified lesions",
                    "criterion": "general health and anatomy",
                    "requirements": [
                        {
                            "requirement_type": "suitability for transrectal ultrasound-MRI fusion biopsy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "General health and anatomy suitable to undergo ... standard 12 core sextent biopsy (Sub-Study 4 only)",
                    "criterion": "general health and anatomy",
                    "requirements": [
                        {
                            "requirement_type": "suitability for standard 12 core sextent biopsy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "sub-study restriction",
                            "expected_value": "Sub-Study 4 only"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* New diagnosis of prostate cancer undergoing additional biopsy evaluation (Sub--Study 4 only)",
            "criterions": [
                {
                    "exact_snippets": "New diagnosis of prostate cancer",
                    "criterion": "prostate cancer diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": "new"
                        }
                    ]
                },
                {
                    "exact_snippets": "undergoing additional biopsy evaluation",
                    "criterion": "biopsy evaluation",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "undergoing additional"
                        }
                    ]
                },
                {
                    "exact_snippets": "(Sub--Study 4 only)",
                    "criterion": "sub-study eligibility",
                    "requirements": [
                        {
                            "requirement_type": "sub-study",
                            "expected_value": "4"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prostate cancer pathologically proven by prostate biopsy (newly diagnosed for Sub-Study 1 and 4)",
            "criterions": [
                {
                    "exact_snippets": "Prostate cancer pathologically proven by prostate biopsy",
                    "criterion": "prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "pathologically proven by prostate biopsy"
                        }
                    ]
                },
                {
                    "exact_snippets": "newly diagnosed for Sub-Study 1 and 4",
                    "criterion": "prostate cancer diagnosis timing",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_timing",
                            "expected_value": "newly diagnosed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Imaging evidence of suspected metastatic disease, including CT, bone scan, MRI, ultrasound or other PET modalities (Sub-Study 3 only)",
            "criterions": [
                {
                    "exact_snippets": "Imaging evidence of suspected metastatic disease",
                    "criterion": "metastatic disease",
                    "requirements": [
                        {
                            "requirement_type": "evidence (imaging)",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "suspicion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including CT, bone scan, MRI, ultrasound or other PET modalities (Sub-Study 3 only)",
                    "criterion": "imaging modality",
                    "requirements": [
                        {
                            "requirement_type": "allowed modalities",
                            "expected_value": [
                                "CT",
                                "bone scan",
                                "MRI",
                                "ultrasound",
                                "PET",
                                "other PET modalities"
                            ]
                        },
                        {
                            "requirement_type": "sub-study restriction",
                            "expected_value": "Sub-Study 3 only"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At least 7 days after most recent prostate biopsy",
            "criterions": [
                {
                    "exact_snippets": "At least 7 days after most recent prostate biopsy",
                    "criterion": "time since most recent prostate biopsy",
                    "requirements": [
                        {
                            "requirement_type": "minimum duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 7,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Two consecutive rising PSA values (Sub-Study 3 only)",
            "criterions": [
                {
                    "exact_snippets": "Two consecutive rising PSA values (Sub-Study 3 only)",
                    "criterion": "PSA values",
                    "requirements": [
                        {
                            "requirement_type": "trend",
                            "expected_value": "rising"
                        },
                        {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "consecutive"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be MALE",
            "criterions": [
                {
                    "exact_snippets": "Must be MALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Karnofsky performance status of at least 70 (Sub-Study 4 only)",
            "criterions": [
                {
                    "exact_snippets": "Karnofsky performance status of at least 70 (Sub-Study 4 only)",
                    "criterion": "Karnofsky performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 70,
                                "unit": ""
                            }
                        },
                        {
                            "requirement_type": "sub-study restriction",
                            "expected_value": "Sub-Study 4 only"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Chemotherapy for prostate cancer",
            "criterions": [
                {
                    "exact_snippets": "Chemotherapy for prostate cancer",
                    "criterion": "chemotherapy for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Unable to lie flat during or tolerate PET/CT",
            "criterions": [
                {
                    "exact_snippets": "Unable to lie flat during or tolerate PET/CT",
                    "criterion": "ability to lie flat during PET/CT",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Unable to lie flat during or tolerate PET/CT",
                    "criterion": "ability to tolerate PET/CT",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin > 3 times the upper limit of normal",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin > 3 times the upper limit of normal",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "times the upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum creatinine > 2 time the upper limit of normal",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine > 2 time the upper limit of normal",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "times upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior history of any other malignancy within the last 2 years, other than skin basal cell or cutaneous superficial squamous cell carcinoma that has not metastasized and superficial bladder cancer.",
            "criterions": [
                {
                    "exact_snippets": "Prior history of any other malignancy within the last 2 years",
                    "criterion": "prior history of malignancy",
                    "requirements": [
                        {
                            "requirement_type": "time since diagnosis",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No prostatectomy scheduled more than 12 hours post imaging (Sub-Study 1 only)",
            "criterions": [
                {
                    "exact_snippets": "No prostatectomy scheduled more than 12 hours post imaging (Sub-Study 1 only)",
                    "criterion": "prostatectomy scheduling time post imaging",
                    "requirements": [
                        {
                            "requirement_type": "time interval",
                            "expected_value": {
                                "operator": "<=",
                                "value": 12,
                                "unit": "hours"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Androgen deprivation therapy for prostate cancer",
            "criterions": [
                {
                    "exact_snippets": "Androgen deprivation therapy for prostate cancer",
                    "criterion": "androgen deprivation therapy",
                    "requirements": [
                        {
                            "requirement_type": "indication",
                            "expected_value": "prostate cancer"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Liver Transaminases > 5 times the upper limit of normal",
            "criterions": [
                {
                    "exact_snippets": "Liver Transaminases > 5 times the upper limit of normal",
                    "criterion": "liver transaminases",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "times the upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Prior pelvic external beam radiation therapy or brachytherapy",
            "criterions": [
                {
                    "exact_snippets": "Prior pelvic external beam radiation therapy",
                    "criterion": "pelvic external beam radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "brachytherapy",
                    "criterion": "brachytherapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Investigational therapy for prostate cancer (Sub-Study 3 Only)",
            "criterions": [
                {
                    "exact_snippets": "Investigational therapy for prostate cancer (Sub-Study 3 Only)",
                    "criterion": "investigational therapy for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "participation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "sub-study",
                            "expected_value": "3"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}